Kolon TissueGene Inc.
03/28/2024 | Press release | Distributed by Public on 03/28/2024 03:26
Outcomes of Annual Meeting of Shareholders
Outcomes of Annual Meeting of Shareholders
| 1. ApprovalㆍReport of Financial Statements | ||||
| 제 25기 | (Mil. KRW) | |||
| A. Non-Consolidated Financial Statements | - Total Assets | 134,910 | - Sales Amount | 3,706 |
| - Total Liabilities | 19,947 | - Operating Income | -20,504 | |
| - Capital Stock | 3 | - Net Income | -17,224 | |
| - Total Shareholders' Equity | 114,963 | *Earnings per Share (KRW) | -1,201 | |
| B. Consolidated Financial Statements | - Total Assets | - | - Sales Amount | - |
| - Total Liabilities | - | - Operating Income | - | |
| - Capital Stock | - | - Net Income | - | |
| - Total Shareholders' Equity | - | *Earnings per Share (KRW) | - | |
| * External Auditor's Opinion | Non-Consolidated Financial Statements | Unqualified Opinion | ||
| Consolidated Financial Statements | - | |||
| 2. DecisionㆍReport on Dividend | ||||
| A. Cash Dividend and Dividend in Kind | Class of Dividend | - | ||
| - Details of Assets | - | |||
| Dividend per Share (KRW) | Common Shares | Year-end Dividend | - | |
| InterimㆍQuarterly Dividend | - | |||
| Different Classes of Shares | Year-end Dividend | - | ||
| InterimㆍQuarterly Dividend | - | |||
| Total Dividends(KRW) | - | |||
| Dividend Rate to Market Price(%)(Including Interim Dividend) | Common Shares | - | ||
| Different Classes of Shares | - | |||
| B. Stock Dividend | Stock Dividend Rate(%) | Common Shares | - | |
| Different Classes of Shares | - | |||
| Total Stock Dividends | Common Shares | - | ||
| Different Classes of Shares | - | |||
| 3. Appointment of Directors, etc.(As of the Appointment Date) | ||||
| A. Details of Appointment | (상근)사내이사 김정인 재선임 | |||
| B. Number of Outside Directors after Appointment | Total Number of Directors | 4 | ||
| Total Number of Outside Directors | 1 | |||
| Outside Director Appointment Ratio(%) | 25 | |||
| C. Number of Auditors after Appointment | Standing Auditor | 1 | ||
| Non-Standing Auditor | - | |||
| D. Members of Audit Committee after Appointment | Members of Audit Committee who are Outside Directors | - | ||
| Members of Audit Committee who are not Outside Directors | - | |||
| 4. Details of Other Resolutions |
제 1호 의안 : 제25기 (2023.01.01~2023.12.31) 재무제표 승인의 건 → 원안대로 승인 가결 제 2호 의안 : 이사 선임 승인의 건 사내이사 김정인 선임 승인의 건 → 원안대로 승인 가결 제 3호 의안 : 이사 보수한도 승인의 건 → 원안대로 승인 가결 제 4호 의안 : 감사 보수한도 승인의 건 → 원안대로 승인 가결 |
|||
| 5. Date of General Meeting of Shareholde | 2024-03-28 | |||
| 6. Other references useful for making investment decisions | ||||
| - | ||||
| ※Title and date of other disclosure related to this one |
2024-03-13 주주총회소집공고 2024-03-13 주주총회소집결의 2023-12-13 기타 경영사항(자율공시)(제25기 정기주주총회 권리주주 확정을 위한 증권예탁증권(KDR) 기준일 설정 공고) |
Appointment Details of Directors
| Name | Date of Birth(Year and month) | Term of Office | Newly Appointed | Curriculum Vitae(Including Present Position) |
| 김정인 | 1978-09 | 3 | Reappointed |
- (주)코오롱 경영관리실 수석 - Kolon TissueGene, Inc. CFO |